Board of Scientific Counselors, National Institute for Occupational Safety and Health (BSC, NIOSH), 13122 [2017-04620]
Download as PDF
<![CDATA[
13122
Federal Register / Vol. 82, No. 45 / Thursday, March 9, 2017 / Notices
(404) 498–2741; or via email at
NAnderson@cdc.gov.
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
Notices pertaining to announcements of
meetings and other committee
management activities, for the Centers
for Disease Control and Prevention and
the Agency for Toxic Substances and
Disease Registry.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. 2017–04621 Filed 3–8–17; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
asabaliauskas on DSK3SPTVN1PROD with NOTICES
Board of Scientific Counselors,
National Institute for Occupational
Safety and Health (BSC, NIOSH)
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces the following meeting for the
aforementioned committee:
Time and Date: 8:30 a.m.–12:45 p.m.,
EDT, April 12, 2017.
Place: 1095 Willowdale Road,
Morgantown, WV 26505. The meeting is
also available via webcast.
Status: This meeting is open to the
public, limited only by the space
available. The meeting room
accommodates approximately 50
people. The public is welcome to
participate during the public comment
period, 9:20 a.m.–9:30 a.m. EDT, April
12, 2017. Please note that the public
comment period ends at the time
indicated above or following the last
call for comments, whichever is earlier.
Members of the public who want to
comment must sign up by providing
their name by mail, email, or telephone,
at the addresses provided below by
April 7, 2017. Each commenter will be
provided up to five minutes for
comment. A limited number of time
slots are available and will be assigned
on a first come-first served basis.
Written comments will also be accepted
from those unable to attend the public
session via an on-line form at the
following Web site: https://www.cdc.gov/
niosh/bsc/contact.html. The meeting is
also open to the public via webcast. If
you wish to attend in person or by
webcast, please see the NIOSH Web site
to register (https://www.cdc.gov/niosh/
VerDate Sep<11>2014
17:43 Mar 08, 2017
Jkt 241001
bsc/) or call (404–498–2539) at least five
business days in advance of the
meeting. Teleconference is available
toll-free; please dial (888) 397–9578,
Participant Pass Code 63257516. Adobe
Connect webcast will be available at
https://odniosh.adobeconnect.com/
nioshbsc/ for participants wanting to
connect remotely.
Purpose: The Secretary, the Assistant
Secretary for Health, and by delegation
the Director, Centers for Disease Control
and Prevention, are authorized under
Sections 301 and 308 of the Public
Health Service Act to conduct directly
or by grants or contracts, research,
experiments, and demonstrations
relating to occupational safety and
health and to mine health. The Board of
Scientific Counselors provides guidance
to the Director, National Institute for
Occupational Safety and Health on
research and prevention programs.
Specifically, the Board provides
guidance on the Institute’s research
activities related to developing and
evaluating hypotheses, systematically
documenting findings and
disseminating results. The Board
evaluates the degree to which the
activities of the National Institute for
Occupational Safety and Health: (1)
Conform to appropriate scientific
standards, (2) address current, relevant
needs, and (3) produce intended results.
Matters for Discussion: NIOSH
Director’s update; occupational motor
vehicle safety, the nanotoxicolgy
program, flu-related research, and mold
investigations.
Agenda items are subject to change as
priorities dictate.
An agenda is also posted on the
NIOSH Web site (https://www.cdc.gov/
niosh/bsc/). Members of the public who
wish to address the NIOSH BSC are
requested to contact the Executive
Secretary for scheduling purposes (see
contact information below).
Alternatively, written comments to the
BSC may be submitted via an on-line
form at the following Web site: https://
www.cdc.gov/niosh/bsc/contact.html.
Contact Person for More Information:
Paul J. Middendorf, Ph.D., Executive
Secretary, BSC, NIOSH, CDC, 1600
Clifton Road NE., MS–E20, Atlanta, GA
30329–4018, telephone (404) 498–2500,
fax (404) 498–2526.
The Director, Management Analysis
and Services Office has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities, for both the
Centers for Disease Control and
PO 00000
Frm 00034
Fmt 4703
Sfmt 4703
Prevention and the Agency for Toxic
Substances and Disease Registry.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention (CDC).
[FR Doc. 2017–04620 Filed 3–8–17; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[Docket Number CDC–2017–0017, NIOSH
153–D]
Proposed Revised Definitions for the
Levels of Evidence for NIOSH Skin
Notation Profiles; Request for
Comment
National Institute for
Occupational Safety and Health
(NIOSH) of the Centers for Disease
Control and Prevention (CDC),
Department of Health and Human
Services (HHS).
ACTION: Request for comments.
AGENCY:
The National Institute for
Occupational Safety and Health
(NIOSH) of the Centers for Disease
Control and Prevention (CDC) proposes
to clarify the definitions for ‘sufficient’,
‘limited’, and ‘insufficient’ levels of
evidence for the designation of NIOSH
skin notations. In NIOSH Current
Intelligence Bulletin (CIB) 61—A
Strategy for Assigning New NIOSH Skin
Notations, Appendix E.2, Evaluation of
data, pp. 41–42 [https://www.cdc.gov/
niosh/docs/2009-147/pdfs/2009147.pdf] these levels of evidence are
defined as the following:
‘‘Data sets classified as sufficient are
those that include human and/or animal
toxicity studies conducted according to
standardized protocols and that provide
in-depth descriptions of the exposure
conditions and study findings. Data sets
classified as limited via the qualitative
ranking scheme contain either human
and/or animal studies conducted by
non-standardized protocols or contain
incomplete descriptions of the exposure
conditions and study findings. Data sets
classified as insufficient include studies
that primarily either did not apply
standard protocols or did not provide an
in-depth description of the exposure
conditions or study findings. Data sets
that receive the insufficient ranking will
not be used as the basis for the NIOSH
skin notation.’’
NIOSH proposes to clarify the
definitions for the sufficient, limited,
SUMMARY:
E:\FR\FM\09MRN1.SGM
09MRN1
]]>Agencies
[Federal Register Volume 82, Number 45 (Thursday, March 9, 2017)]
[Notices]
[Page 13122]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-04620]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Board of Scientific Counselors, National Institute for
Occupational Safety and Health (BSC, NIOSH)
In accordance with section 10(a)(2) of the Federal Advisory
Committee Act (Pub. L. 92-463), the Centers for Disease Control and
Prevention (CDC) announces the following meeting for the aforementioned
committee:
Time and Date: 8:30 a.m.-12:45 p.m., EDT, April 12, 2017.
Place: 1095 Willowdale Road, Morgantown, WV 26505. The meeting is
also available via webcast.
Status: This meeting is open to the public, limited only by the
space available. The meeting room accommodates approximately 50 people.
The public is welcome to participate during the public comment period,
9:20 a.m.-9:30 a.m. EDT, April 12, 2017. Please note that the public
comment period ends at the time indicated above or following the last
call for comments, whichever is earlier. Members of the public who want
to comment must sign up by providing their name by mail, email, or
telephone, at the addresses provided below by April 7, 2017. Each
commenter will be provided up to five minutes for comment. A limited
number of time slots are available and will be assigned on a first
come-first served basis. Written comments will also be accepted from
those unable to attend the public session via an on-line form at the
following Web site: https://www.cdc.gov/niosh/bsc/contact.html. The
meeting is also open to the public via webcast. If you wish to attend
in person or by webcast, please see the NIOSH Web site to register
(https://www.cdc.gov/niosh/bsc/) or call (404-498-2539) at least five
business days in advance of the meeting. Teleconference is available
toll-free; please dial (888) 397-9578, Participant Pass Code 63257516.
Adobe Connect webcast will be available at https://odniosh.adobeconnect.com/nioshbsc/ for participants wanting to connect
remotely.
Purpose: The Secretary, the Assistant Secretary for Health, and by
delegation the Director, Centers for Disease Control and Prevention,
are authorized under Sections 301 and 308 of the Public Health Service
Act to conduct directly or by grants or contracts, research,
experiments, and demonstrations relating to occupational safety and
health and to mine health. The Board of Scientific Counselors provides
guidance to the Director, National Institute for Occupational Safety
and Health on research and prevention programs. Specifically, the Board
provides guidance on the Institute's research activities related to
developing and evaluating hypotheses, systematically documenting
findings and disseminating results. The Board evaluates the degree to
which the activities of the National Institute for Occupational Safety
and Health: (1) Conform to appropriate scientific standards, (2)
address current, relevant needs, and (3) produce intended results.
Matters for Discussion: NIOSH Director's update; occupational motor
vehicle safety, the nanotoxicolgy program, flu-related research, and
mold investigations.
Agenda items are subject to change as priorities dictate.
An agenda is also posted on the NIOSH Web site (https://www.cdc.gov/niosh/bsc/). Members of the public who wish to address the NIOSH BSC
are requested to contact the Executive Secretary for scheduling
purposes (see contact information below). Alternatively, written
comments to the BSC may be submitted via an on-line form at the
following Web site: https://www.cdc.gov/niosh/bsc/contact.html.
Contact Person for More Information: Paul J. Middendorf, Ph.D.,
Executive Secretary, BSC, NIOSH, CDC, 1600 Clifton Road NE., MS-E20,
Atlanta, GA 30329-4018, telephone (404) 498-2500, fax (404) 498-2526.
The Director, Management Analysis and Services Office has been
delegated the authority to sign Federal Register notices pertaining to
announcements of meetings and other committee management activities,
for both the Centers for Disease Control and Prevention and the Agency
for Toxic Substances and Disease Registry.
Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease
Control and Prevention (CDC).
[FR Doc. 2017-04620 Filed 3-8-17; 8:45 am]
BILLING CODE 4163-18-P
